Previous 10 | Next 10 |
Nevro Announces Preliminary Fourth-Quarter and Full-Year 2023 Revenue Results PR Newswire Fourth-Quarter 2023 Worldwide Revenue Exceeds Company's Expectations Announces Restructuring to Support Company's Long-Term Growth and Profitability REDWOOD CITY, Calif....
Nevro to Present at 42nd Annual J.P. Morgan Healthcare Conference PR Newswire REDWOOD CITY, Calif. , Jan. 4, 2024 /PRNewswire/ -- Nevro Corp. (NYSE: NVRO), a global medical device company that is delivering comprehensive, life-changing solutions for the trea...
2023-12-21 15:39:30 ET More on Nevro Nevro Corp. (NVRO) Q3 2023 Earnings Call Transcript Nevro gains after activist Engaged discloses stake Nevro acquires medical technology company Vyrsa Technologies Seeking Alpha’s Quant Rating on Nevro Histo...
2023-12-20 13:10:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...
2023-12-11 09:43:44 ET More on Nevro Nevro Corp. (NVRO) Q3 2023 Earnings Call Transcript Nevro acquires medical technology company Vyrsa Technologies Nevro Q3 2023 Earnings Preview Seeking Alpha’s Quant Rating on Nevro Historical earnings data ...
2023-11-30 17:44:54 ET More on Nevro Nevro Corp. (NVRO) Q3 2023 Earnings Call Transcript Nevro Q3 2023 Earnings Preview Seeking Alpha’s Quant Rating on Nevro Historical earnings data for Nevro Financial information for Nevro For further...
Nevro Announces Acquisition of Vyrsa™ Technologies PR Newswire Refinances with $200M Structured Debt Maturing in 2029 REDWOOD CITY, Calif. , Nov. 30, 2023 /PRNewswire/ -- Nevro Corp. (NYSE: NVRO), a global medical device company that is deliver...
Nevro Delivers Long-Term Relief with High-Frequency Spinal Cord Stimulation: 24-Month Data Demonstrates Profound Improvements for Non-Surgical Refractory Back Pain PR Newswire Data Published in Journal of Neurosurgery: Spine Highlight Lasting Pain Relief, Enhanced Function, Qu...
2023-11-01 20:17:14 ET Nevro Corp. (NVRO) Q3 2023 Results Conference Call November 01, 2023 04:30 PM ET Company Participants Kevin Thornal - President and Chief Executive Officer Rod MacLeod - Senior Vice President and Chief Financial Officer Conference Call Pa...
2023-11-01 16:23:01 ET Nevro press release ( NYSE: NVRO ): Q3 GAAP EPS of -$0.65 beats by $0.12 . Revenue of $103.9M (+3.4% Y/Y) beats by $8.02M . Expects fourth quarter of 2023 worldwide revenue of approximately $108 million to $110 million. Expects fourth...
News, Short Squeeze, Breakout and More Instantly...
Nevro to Present at BofA Securities 2024 Healthcare Conference PR Newswire REDWOOD CITY, Calif. , May 9, 2024 /PRNewswire/ -- Nevro Corp. (NYSE: NVRO), a global medical device company that is delivering comprehensive, life-changing solutions for the treatment of ...
Nevro Reports First-Quarter 2024 Financial Results PR Newswire Announces Additional Restructuring Steps to Advance Strategy and Accelerate Profitability Raises Adjusted EBITDA Guidance and Reaffirms Revenue Guidance for Full-Year 2024 Promotes Christofer Ch...
Aterian Inc. (ATER) is expected to report for Q1 2024 Dorman Products Inc. (DORM) is expected to report $0.82 for Q1 2024 Hillman Solutions Corp. (HLMN) is expected to report $0.08 for Q1 2024 Wake Forest Bancshares, Inc. (WAKE) is expected to report for quarter end 2024-03-31 Inn...